Holly B. Kordasiewicz, EVP, Chief Development Officer at Ionis Pharmaceuticals, sold IONS on Jul 7, 2026
Data as of Oct 16
▼ SELL$30.5K362 shares at $84.30Holly B. Kordasiewicz EVP, Chief Development OfficerIONS Ionis Pharmaceuticals Inc
- Traded
- Jul 7, 2026
- Disclosed
- Jul 9, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
IONS since disclosure
−33.2%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund
Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.